Delivery Order SPE2DB22D3004-SPE2DB24FPE74
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $19,725.93 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide SKYRIZI 150 MG/ML PENML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $11,827.51 to Amerisourcebergen Drug Corp, a subsidiary of the for-profit company Amerisourcebergen Corporation. The contract is for the delivery of SKYRIZI 150 MG/ML PENML pharmaceutical products, with a completion date of January 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, with a potential value of up to $999,999,999.00 and a performance period through...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML pharmaceutical products. The contract has a potential value of $11,827.51 and a completion date of February 20, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $21,058.77, is for the supply of the pharmaceutical product SKYRIZI 150 MG/ML PENML. Amerisourcebergen Drug Corp has an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide SKYRIZI 150 MG/ML PENML, a specialty pharmaceutical product. The $26,194.53 contract has a performance period through March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and also holds an indefinite delivery contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $23,655.02 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a prescription medication, to support military treatment programs. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,819.88 to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML, a specialty pharmaceutical product. Issued on August 11, 2025, with an ultimate completion date of August 12, 2025, this firm fixed-price delivery order represents a competitively awarded, non-set-aside contract. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The $17,320.75 Firm Fixed Price contract is for the supply of the pharmaceutical product SKYRIZI 150 MG/ML PENML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide SKYRIZI 150 MG/ML PENML, a medication. The award has a ceiling value of $24,039.78 and a completion date of June 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which enables the company to supply a wide range of pharmaceutical products and...
- The Defense Logistics Agency awarded a delivery order valued at approximately $55,954.56 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 MG/ML in pen/milliliter format. This is a firm fixed price, non-set-aside contract with a completion date of September 30, 2025, issued on September 29, 2025. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPE74Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of SKYRIZI 150 MG/ML PENML pharmaceutical product. The contract has a potential value of $18,678.07 and a completion date of February 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.7k | 2/2/24 |